Harmony Biosciences
(NASDAQ:HRMY)
$30.14
-1.14[-3.64%]
At close: May 10
$30.14
0[0.00%]
After Hours: 4:00PM EDT
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest
75%
Overview Rating
Good
Technicals Analysis
100
0100
Financials Analysis
60
0100

Harmony Biosciences Stock (NASDAQ:HRMY), Quotes and News Summary

Harmony Biosciences Stock (NASDAQ: HRMY) stock price, news, charts, stock research, profile.

Open$31.450
Close$30.140
Volume / Avg.250.707K / 427.443K
Day Range30.100 - 31.570
52 Wk Range18.611 - 39.265
Market Cap$1.712B
P/E Ratio13.483
Dividend Yield-
ExchangeNASDAQ
RSI
47
Short Interest
50.91%
Days to Cover15.91

Recent News

Looking for a Growth Stock? 3 Reasons Why Harmony Biosciences is a Solid Choice
Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a growth stock that can live up to its true potential can be a tough task.
Zacks
Harmony Biosciences Expands It CNS-Focused Pipeline With Epilepsy Candidate, Q1 Earnings Beat Street View
Harmony Biosciences expands its late-stage CNS pipeline with the acquisition of Epygenix Therapeutics, bolstering its rare epilepsy offerings. Harmony's Q1 performance shows robust growth, with adjusted EPS surpassing expectations.
Vandana Singh
Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 80% to $6.14 after the company announced it received notice of acceptance from the Australian patent office for its patent application for Combination of Opioids and N-Acylethanolamines for pain treatment.
Lisa Levin
60%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
2
Jan
5
Feb
1
Mar
4
Apr
1
May
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
3.6
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
HRMY
SUPN

FAQ

Q

How do I buy Harmony Biosciences (HRMY) stock?

A

You can purchase shares of Harmony Biosciences (NASDAQ: HRMY) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Harmony Biosciences's (HRMY) competitors?

A

Other companies in Harmony Biosciences’s space includes: Supernus Pharmaceuticals (NASDAQ:SUPN), Verona Pharma (NASDAQ:VRNA), Tarsus Pharmaceuticals (NASDAQ:TARS), Neumora Therapeutics (NASDAQ:NMRA) and ANI Pharmaceuticals (NASDAQ:ANIP).

Q

What is the target price for Harmony Biosciences (HRMY) stock?

A

The latest price target for Harmony Biosciences (NASDAQ: HRMY) was reported by Needham on Wednesday, May 1, 2024. The analyst firm set a price target for 52.00 expecting HRMY to rise to within 12 months (a possible 72.53% upside). 35 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Harmony Biosciences (HRMY)?

A

The stock price for Harmony Biosciences (NASDAQ: HRMY) is $30.14 last updated May 10, 2024 at 4:00 PM EDT.

Q

Does Harmony Biosciences (HRMY) pay a dividend?

A

There are no upcoming dividends for Harmony Biosciences.

Q

When is Harmony Biosciences (NASDAQ:HRMY) reporting earnings?

A

Harmony Biosciences’s Q2 earnings are confirmed for Tuesday, July 30, 2024.

Q

Is Harmony Biosciences (HRMY) going to split?

A

There is no upcoming split for Harmony Biosciences.

Q

What sector and industry does Harmony Biosciences (HRMY) operate in?

A

Harmony Biosciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

People Also Watch